Mechanical Ventilation and Hospital-Acquired Venous Thromboembolism Among Critically Ill Children

Hosp Pediatr. 2022 Dec 1;12(12):1099-1109. doi: 10.1542/hpeds.2022-006697.

Abstract

Objectives: To estimate the occurrence of, and evaluate associations between, hospital-acquired venous thromboembolism (HA-VTE) and invasive mechanical ventilation (MV) among children hospitalized in the PICU.

Methods: We performed a multicenter, retrospective cohort study comparing HA-VTE frequencies among subjects <18 years of age hospitalized in the PICU from January 2018 through December 2019 among 47 participating centers, via the Pediatric Health Information Systems registry. We excluded perinatal encounters, those with VTE present at admission, and those with observational status. The primary outcome was the proportion of HA-VTE events before hospital discharge, including extremity deep venous thrombosis, pulmonary embolism, and organ-specific deep venous thrombosis. The HA-VTE frequencies were compared using χ2 tests. The association between HA-VTE and MV was investigated via multivariable logistic regression, adjusting for previously described VTE risk factors.

Results: Of the 205 231 PICU encounters identified for study, 70 829 (34.5%) underwent MV. The occurrence of HA-VTE was 2.2% and was greater among children who received, versus did not receive, MV (4.4% versus 1.1%, P < .001). Multivariable logistic regression revealed significant association between MV and HA-VTE (odds ratio 2.51, 95% confidence interval 2.33-2.69; P < .001).

Conclusions: In this multicenter, retrospective, registry-based cohort study, HA-VTE were diagnosed in 2.2% of critically-ill children, and after adjustment for central venous catheterization, MV independently increased the risk of HA-VTE 2.5-fold. These findings warrant prospective validation to inform the design of future risk-stratified clinical trials of thromboprophylaxis in critically-ill children.

Publication types

  • Multicenter Study

MeSH terms

  • Anticoagulants / therapeutic use
  • Child
  • Cohort Studies
  • Critical Illness / epidemiology
  • Critical Illness / therapy
  • Hospitals
  • Humans
  • Respiration, Artificial
  • Retrospective Studies
  • Risk Factors
  • Venous Thromboembolism* / diagnosis
  • Venous Thrombosis*

Substances

  • Anticoagulants